BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 9422562)

  • 21. Late rectal toxicity after image-based high-dose-rate interstitial brachytherapy for postoperative recurrent and/or residual cervical cancers: EQD2 predictors for Grade ≥II toxicity.
    Chopra S; Dora T; Engineer R; Mechanery S; Agarwal P; Kannan S; Ghadi Y; Swamidas J; Mahantshetty U; Shrivastava SK
    Brachytherapy; 2015; 14(6):881-8. PubMed ID: 26409708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rectal complications in patients with carcinoma of the cervix treated with concomitant cisplatin and external beam irradiation with high dose rate brachytherapy: a dosimetric analysis.
    Clark BG; Souhami L; Roman TN; Evans MD; Pla C
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1243-50. PubMed ID: 8175412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of morbidity after external radiotherapy and intracavitary brachytherapy in 771 patients with carcinoma of the uterine cervix or endometrium.
    Yalman D; Arican A; Ozsaran Z; Celik OK; Yürüt V; Esassolak M; Haydaroglu A
    Eur J Gynaecol Oncol; 2002; 23(1):58-62. PubMed ID: 11876395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De-escalation of the cumulative central radiation dose according to the tumor response can reduce rectal toxicity without compromising the treatment outcome in patients with uterine cervical cancer.
    Kim KH; Kim S; Kim GE; Koom WS; Kim SW; Nam EJ; Suh CO; Kim YB
    Gynecol Oncol; 2015 Dec; 139(3):439-46. PubMed ID: 26456139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer.
    Chen SW; Liang JA; Yeh LS; Yang SN; Shiau AC; Lin FJ
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):663-71. PubMed ID: 15380604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Normal tissue tolerance to external beam radiation therapy: rectum].
    Blanchard P; Chapet O
    Cancer Radiother; 2010 Jul; 14(4-5):354-8. PubMed ID: 20570201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis.
    Snyder KM; Stock RG; Hong SM; Lo YC; Stone NN
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):335-41. PubMed ID: 11380219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: a dosimetric analysis.
    Roeske JC; Mundt AJ; Halpern H; Sweeney P; Sutton H; Powers C; Rotmensch J; Waggoner S; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):351-8. PubMed ID: 9069307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late rectal toxicity after low-dose-rate brachytherapy: incidence, predictors, and management of side effects.
    Kishan AU; Kupelian PA
    Brachytherapy; 2015; 14(2):148-59. PubMed ID: 25516492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and Preliminary Evaluation of a Murine Model of Chronic Radiation-Induced Proctitis.
    Ashcraft KA; Miles D; Sunday ME; Choudhury KR; Young KH; Palmer GM; Patel P; Woska EC; Zhang R; Oldham M; Dewhirst MW; Koontz BF
    Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1194-1201. PubMed ID: 30012529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of vascular endothelial growth factor and its correlation with clinical symptoms and endoscopic findings in patients with chronic radiation proctitis.
    Trzcinski R; Dziki A; Brys M; Moszynska-Zielinska M; Chalubinska-Fendler J; Mik M; Kujawski R; Dziki L
    Colorectal Dis; 2018 Apr; 20(4):321-330. PubMed ID: 28963746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive factors for response and toxicity after brachytherapy for rectal cancer; results from the HERBERT study.
    Rijkmans EC; Marijnen CAM; van Triest B; Ketelaars M; Cats A; Inderson A; van den Ende RPJ; Laman MS; Kerkhof EM; Nout RA
    Radiother Oncol; 2019 Apr; 133():176-182. PubMed ID: 30935576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rectal wall dose-volume effect of pre- or post KUSHEN Ningjiaos relationship with 3D brachytherapy in cervical cancer patients.
    Li X; Xiao C; Kong Y; Guo W; Zhan W; Li G; Wang X; Zhang B; Gao L
    Radiat Oncol; 2019 Aug; 14(1):149. PubMed ID: 31429773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
    Lee SW; Suh CO; Chung EJ; Kim GE
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose.
    Smit WG; Helle PA; van Putten WL; Wijnmaalen AJ; Seldenrath JJ; van der Werf-Messing BH
    Int J Radiat Oncol Biol Phys; 1990 Jan; 18(1):23-9. PubMed ID: 2298625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of correlation between rectal complications and rectal dose following high dose rate intracavitary radiotherapy in patients with uterine cervix cancer: in vivo dosimetric analysis.
    Shin KH; Huh SJ; Chie EK; Choi DR; Lim DH; Kim MK; Lee KC; Kim DY; Ahn YC
    Radiat Med; 1999; 17(4):289-93. PubMed ID: 10510902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between acute histopathological changes of rectal walls and late radiation proctitis following radiotherapy for prostate cancer.
    Campostrini F; Remo A; Astati L; Zorzi M; Capodaglio G; Buffoli A; Moretti G; Della Monica B; Zanella C; Verlato G
    Strahlenther Onkol; 2020 Jul; 196(7):617-627. PubMed ID: 32166451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prediction of late rectal complications following the treatment of uterine cervical cancer by high-dose-rate brachytherapy.
    Chen SW; Liang JA; Yang SN; Liu RT; Lin FJ
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):955-61. PubMed ID: 10863065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors for predicting rectal dose of high-dose-rate intracavitary brachytherapy after pelvic irradiation in patients with cervical cancer: a retrospective study with radiography-based dosimetry.
    Huang EY; Wang CJ; Lan JH; Chen HC; Fang FM; Hsu HC; Huang YJ; Wang CY; Wang YM
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):490-5. PubMed ID: 19467795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.